Immune thrombotic thrombocytopenic purpura in patients over 60 years of age : Diagnostic pitfalls and treatment strategy
© 2023 British Society for Haematology and John Wiley & Sons Ltd..
Real-world registry studies of older patients with iTTP highlight diagnostic difficulties in comparison to patients less than 60 years of age with greater risk of renal injury, atypical neurological features and less profound cytopenia, which can result in diagnostic delays. However, there is no clear signal of significantly increased toxicity from full active treatment. Commentary on: Gómez-Seguí et al. Immune thrombotic thrombocytopenic purpura in older patients: results from the Spanish TTP Registry (REPTT). Br J Haematol 2023;203:860-871.
| Errataetall: |
CommentOn: Br J Haematol. 2023 Dec;203(5):860-871. - PMID 37723363 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:203 |
|---|---|
| Enthalten in: |
British journal of haematology - 203(2023), 5 vom: 01. Dez., Seite 704-705 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lester, Will [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ADAMTS13 Protein |
|---|
| Anmerkungen: |
Date Completed 29.11.2023 Date Revised 06.03.2024 published: Print-Electronic CommentOn: Br J Haematol. 2023 Dec;203(5):860-871. - PMID 37723363 Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjh.19123 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362454442 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362454442 | ||
| 003 | DE-627 | ||
| 005 | 20240306232433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjh.19123 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1318.xml |
| 035 | |a (DE-627)NLM362454442 | ||
| 035 | |a (NLM)37749067 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lester, Will |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immune thrombotic thrombocytopenic purpura in patients over 60 years of age |b Diagnostic pitfalls and treatment strategy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2023 | ||
| 500 | |a Date Revised 06.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Br J Haematol. 2023 Dec;203(5):860-871. - PMID 37723363 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 British Society for Haematology and John Wiley & Sons Ltd. | ||
| 520 | |a Real-world registry studies of older patients with iTTP highlight diagnostic difficulties in comparison to patients less than 60 years of age with greater risk of renal injury, atypical neurological features and less profound cytopenia, which can result in diagnostic delays. However, there is no clear signal of significantly increased toxicity from full active treatment. Commentary on: Gómez-Seguí et al. Immune thrombotic thrombocytopenic purpura in older patients: results from the Spanish TTP Registry (REPTT). Br J Haematol 2023;203:860-871 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a immune thrombotic thrombocytopenic purpura | |
| 650 | 4 | |a older age | |
| 650 | 4 | |a registry | |
| 650 | 4 | |a renal injury | |
| 650 | 7 | |a ADAMTS13 Protein |2 NLM | |
| 650 | 7 | |a EC 3.4.24.87 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d 1955 |g 203(2023), 5 vom: 01. Dez., Seite 704-705 |w (DE-627)NLM000000396 |x 1365-2141 |7 nnns |
| 773 | 1 | 8 | |g volume:203 |g year:2023 |g number:5 |g day:01 |g month:12 |g pages:704-705 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjh.19123 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 203 |j 2023 |e 5 |b 01 |c 12 |h 704-705 | ||